I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Effects of canagliflozin compared with placebo on major adv..:
Young, TK
;
Li, J-W
;
Kang, A
...
Diabetologia. , 2021
Link:
http://hdl.handle.net/10044/1/91388
RT Journal T1
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program
UL https://suche.suub.uni-bremen.de/peid=base-ftimperialcol:oai:spiral.imperial.ac.uk:10044_1_91388&Exemplar=1&LAN=DE A1 Young, TK A1 Li, J-W A1 Kang, A A1 Heerspink, HJL A1 Hockham, C A1 Arnott, C A1 Neuen, BL A1 Zoungas, S A1 Mahaffey, KW A1 Perkovic, V A1 De Zeeuw, D A1 Fulcher, G A1 Neal, B A1 Jardine, M PB Springer YR 2021 K1 Science & Technology K1 Life Sciences & Biomedicine K1 Endocrinology & Metabolism K1 Baseline HbA(1c) K1 Complications K1 Disease duration K1 Treatment intensity K1 Type 2 diabetes complexity K1 VASCULAR COMPLICATIONS K1 OUTCOMES K1 EMPAGLIFLOZIN K1 DIAGNOSIS K1 TARGETS K1 DEATH K1 RISK K1 AGE K1 Baseline HbA1c K1 1103 Clinical Sciences K1 1114 Paediatrics and Reproductive Medicine K1 1117 Public Health and Health Services JF Diabetologia LK http://hdl.handle.net/10044/1/91388 DO http://hdl.handle.net/10044/1/91388 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)